Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan vs Rabeprazole for Post-EVL Ulcer Prevention
NCT07608536Phase 3Not yet recruiting
- Sponsor
- King George's Medical University
- Start
- May 2026
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
A Phase 3 trial of vonoprazan in Esophageal ulcer, sponsored by King George's Medical University. Planned start May 2026; status: not yet recruiting.
02
Drugs
vonoprazan
03
Conditions
Esophageal ulcer
Beyond the preview
Go deeper on NCT07608536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07608536.